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The approach to the discovery of new anticancer drugs has 
recently evolved from a dependence on empiric cell-based screening 
for antiproliferative effects to a more mechanistically based approach 
that targets the specific molecular lesions thought to be responsible 
for the development and maintenance of the malignant phenotype in 
various forms of cancer.  The challenges in developing better and 
effective cancer drugs are reduction of toxicity and improving efficacy 
and selectivity (cancer-specific targets) by exploiting the differences 
between cancer cells and normal cells.  Past few years several 
thousands of new chemical entities undergo screening in various cell 
cultures but eventually do not achieve drug status due to severe side-
effects.  Ideally, one of the criteria for a drug being good is that it 
should not exhibit any undesirable side-effects on normal cells 
(Albrecht et al., 2008).  Our results indicated that the multi-parameter 
assay platform established in this study could be used to provide 
broader description of the drug property in addition to specific 
activities.  Synthetic compounds are often used as highly potent drugs 
to treat acute leukemia.  (Suh et al., 2003; Hallak et al., 2009; Kang et 
al., 2008).   
Apoptosis is the result of an active, gene-directed process, and 
this phenomenon should be manipulated to develop drugs that 
interact with cell death proteins.  The understanding of apoptosis 
process has provided the basis for novel, targeted therapies that 
specifically induce cell death in carcinoma cell lines or enhance the 
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cytotoxic effects of established chemotherapeutic agents in these cells 
(Pettersson et al., 2000).   Ability to manipulate the machinery of cell 
death is an obvious goal of medical research and effect on regulation 
of apoptosis might lead to new possibilities for cancer treatment 
(Tamatani et al., 2007).  Research has shown enough evidences that 
synthetic products are a potential source of powerful antileukemic 
compounds.  
 Similarly, soft corals are also capable to produce various 
chemical substances, which are toxic to both predators and some 
neighbouring hard corals. Some of these chemicals have properties 
which are beneficial to humans, and can be exploited for various 
medicinal properties including drugs useful for cancer chemotherapy.  
In the present search for synthetic quinazolinyl derivative, a 
biologically active DMQA was powerful cytotoxic compound, which 
induced apoptosis on human monocytoid leukemia cells (THP-1) and 
can be further developed as drug for cancer chemotherapy.    
The results obtained by applying MTT and Trypan blue exclusion 
assays demonstrated that DMQA exhibits marked concentration 
dependent cytotoxic activity on various tumor cell lines which are 
found to be much less compared to the IC50 obtained on normal 
proliferating cell line PBMC (207.93 µM).  The IC50 value was found to 
be least on Thp-1 cell line (2.21 µM) and was selected to study the 
apoptotic pathway.  DMQA is a novel synthetic quinazolinyl derivative 
that exerts a broad spectrum of activity against U937 (human 
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monocyte lymphoma), THP-1 (human acute monocytoid), HL60 
(human myeloid leukemia cells), HeLa (human cervical cancer), Mia-
Pa-Ca-2 (human Caucasian pancreatic carcinoma) A-375 (human 
melanoma), B16-F10 (Mouse Melanoma) and A-431 (epidermal 
carcinoma) cell lines.       
Apoptosis, often limited to a single cell or a small group of cells, 
is characterized by chromatin condensation and internucleosomal 
DNA degradation.  Furthermore, cell shrinkage is accompanied by an 
extensive blebbing of the cell membrane which results in the 
separation of the cell into a number of membrane-bound vesicles 
(apoptotic bodies).  Structural alterations of the cell surface (e.g. 
translocation of phosphatidylserine to the outer cell membrane) 
ensure that apoptotic cells are recognized and phagocytised by either 
macrophages or adjacent epithelial cells [Duvall et al., 1985].  The 
numbers of early apoptotic cells were increased in a concentration-
dependent manner on THP-1 cells treated with DMQA (Fig).  The 
apoptotic features induced by DMQA include inhibition of 
proliferation, structural and biochemical features that characterize 
chromatin condensation, fragmentation and cell shrinkage as 
demonstrated by Trypan blue exclusion assay and fluorescence 
microscopy (Fig).   
      Cell death process (apoptosis) is a characterized by morphological 
and biochemical features occurring at different stages and therefore, 
more high-throughput methods are clearly needed when analyzing 
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numerous samples.  Annexin V can be used in a simple assay for 
early detection of apoptosis.  In normal cells, Phosphatidylserine (PS) 
is located on the inner surface of the plasma membrane.  Apoptotic 
cells bind this phospholipid- binding protein with high affinity due to 
the externalization of phosphatidylserine on the external leaflet of the 
plasma membrane during apoptosis (Martin et al., 1995; Fadok et al; 
1992).  The presence of phosphatidylserine on the outer leaflet of 
apoptotic cells membrane was assessed using Annexin V-cy3/6CFDA 
staining to quantify the amount of cells in the early stage of apoptosis. 
The numbers of early apoptotic cells were increased in a 
concentration-dependent manner on THP-1 cells treated with DMQA 
(Fig. 3.12).   
   Imbalance between cell growth and cell death has been proposed to 
be involved in tumor formation (Smith and Fornace 1996). 
Accordingly, in response to various types of DNA damage, the cell 
cycle checkpoints and cell death signals are activated to stop cell 
growth and to eliminate multiplication of the genetically altered cells. 
Two checkpoints in the cell cycle, G1 and G2, play a very important 
role in the regulation of cells proceeding to S and M phases, 
respectively (Fritsche et al., 1993). Damaged cells stop DNA replication 
at G1 or G2 phase, presumably allowing the repair systems to 
function before the next round of cell cycle.  Activation of the 
apoptotic cell death pathway is a safeguard to remove unrepairably 
damaged cells. Several cellular effector molecules, including p53, are 
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involved in arresting damaged cells at these checkpoints and inducing 
apoptosis. Up-regulation of the p53 protein is a common cellular 
response in many cell types exposed to various DNA damaging agents 
(Thompson CB, 1995; O’Connor, PM, 1997).  Cell cycle analysis 
showed a sub-G1 population on DMQA treated THP-1 cells, which 
indicated that the cell death was caused by apoptosis.  The maximum 
number of cells arrested in sub G1 phase were observed at 24h 
(36.36%) compared to 6h (6.11%) indicating a time dependent effect of 
DMQA (Fig 3.13).  
Cleavage of chromosomal DNA into oligonucleosomal size 
fragments is an integral part of apoptosis. Elegant biochemical work 
identified the DNA fragmentation factor (DFF) as a major apoptotic 
endonuclease for DNA fragmentation in vitro.  DNA cleavage during 
apoptosis occurs at sites between nucleosomes, protein-containing 
structures that occur in chromatin at ~200-BP intervals.  DNA 
fragmentation is often analyzed using agarose gel electrophoresis to 
demonstrate a "ladder" pattern at ~200-BP intervals.  Apoptosis 
induced by DMQA clearly demonstrated a dose dependent increase in 
DNA ladder formation (Fig. 3.15). 
        In addition to the cell membrane changes and death receptors, 
mitochondria play a central role in the transduction of apoptotic 
signals triggered by many stimuli. Mitochondrial participation in 
apoptosis was connected with the collapse of membrane potential that 
was considered a point of no return in the death cascade (Renz, 2001) 
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and mitochondrion has thus been becoming the target for 
chemotherapeutic agents (Costantini et al., 2000). Etoposide, 
doxorubicin, camptothecin and cisplatin (Sancho et al., 2003) are 
wonderful examples of mitochondrial-mediated apoptosis. More 
recently, many novel secondary metabolites with potential 
chemotherapeutic development include halichondrin B (Towle et al., 
2001), Peloruside A (Hood et al., 2002) and Spongistatin 1 (Schyschka 
et al., 2008) were of marine origin.  
The reduction of Δψmt is an early event in the apoptotic cascade 
and may be a sign of mitochondrial swelling and disruption of the 
outer mitochondrial membrane (Ly et al., 2003).  To address if the title 
compounds, affect upon irradiation the Δψmt, the fluorescence of the 
dye JC-1 a reliable mitochondrial potential probe was monitored 
(Salvioli et al., 1997). Translocation of cytochrome c from the 
mitochondrial intermembrane space to the cytosol occurs in 
consequence of outer mitochondrial membrane permeabilisation 
(OMP). Inner mitochondrial membrane permeabilisation (IMP) is 
manifested as a dissipation of the transmembrane potential (Δψm). In 
most cases mitochondrial dysfunction implicates both, OMP and IMP 
(Ella et al., 1998). Determination of a reduction in Δψm by using the 
fluorochrome JC-1 indirectly evidenced reduction in mitochondrial 
membrane potential in a concentration dependent manner (1-3µg/ml 
for 12h) in Thp-1 cells treated with DMQA (3.17).  The decrease of 
Δψm preceded the release of cytochrome c.   
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Bcl-2 family members are major regulators of the mitochondria-
initiated caspase activation pathway [Forte and Bernardi, 2006] and 
are classified as two groups in this family, anti-apoptotic members 
(e.g. Bcl-2 and Bcl-xL) and pro-apoptotic members (e.g. Bid and Bcl-
xS) (Chan and Yu et al., 2004).  Inadequate Bcl-2 protein expressions 
are also likely to enhance tumor cell survival.  The present study was 
designed to gain insights into the role of these Bcl-2 family members 
in DMQA-mediated apoptosis.  It is a known phenomenon that Bcl-2 
family of proteins regulates apoptosis and that the gene products of 
Bcl-2 and Bax play important roles in apoptotic cell death [Jacobson 
and Raff, 1995].  DMQA mediated apoptotic cell death in Thp-1 cells 
revealed an increase in the expression of proapoptotic protein Bax and 
a decrease in the level of antiapoptotic protein Bcl-2 (Fig. 3.18).  
Together these data clearly indicate that DMQA induces mitochondrial 
dysfunction in Thp-1 cells. 
Caspases, intracellular cystein proteases, play an essential role 
in the initiation and execution phases of chemical-induced apoptotic 
cell death.  However, the number of studies, proposing an additional 
caspase-independent cell death is growing (Mathiasen et al., 1999, 
Roberts et al., 1999, Nylandsted et al., 2000).    As it is confirmed in 
the present work, A decrease in level of executioner procaspases-3 and 
initiator procaspase-9 was observed in THP-1 cells exposed to DMQA, 
indicating that apoptosis was dependent upon successive activation of 
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caspases.  In contrast, involvement of mitochondria has been found in 
caspase-9 activation [Green and Reed, 1998]. (Fig.3.18). 
PARP is a protein involved in a number of cellular processes 
involving mainly DNA repair and programmed cell death. This 
inactivation of PARP has been proposed to prevent depletion of NAD (a 
PARP substrate) and ATP, which are thought to be required for later 
events in apoptosis.  PARP is a 113 kDa nuclear protein which can 
exist as a homo- or hetero-dimer, and is strongly activated by DNA 
strand breaks. This protein acts as a molecular “nick sensor” and 
functions in base excision repair, poly(ADPribosyl)ation of acceptor 
proteins involved in chromatin architecture and DNA metabolism, and 
participates in protein modification to enhance or repress 
transcription. PARP was subsequently shown to be cleaved into 89-
 and 24-KDa fragments that contain the active site and the DNA-
binding domain of the enzyme, respectively, during drug-induced 
apoptosis in a variety of cells (Kaufmann et al., 1993; Nicholson et al., 
1995). Such cleavage essentially inactivates the enzyme by destroying 
its ability to respond to DNA strand breaks.  Western blotting analysis 
revealed that DMQA (24h) induced cleavage of PARP into 85KD 
fragment in concentration dependent manner (1, 2 and 3 µg/ml) in 
Thp-1 cells (Fig. 3.18).  It is evident that induction of caspase-3 led to 
the cleavage of PARP (115 kDa), a substrate of caspase-3 to produce a 
fragment (85-kDa) with a concomitant decrease of 115-kDa protein, 
which occurs at apoptosis onset (Lazebnik et al., 1994). 
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Active caspase recognizes several molecules as substrates 
during apoptosis. For example, ICAD (inhibitor of caspase-activated 
deoxyribonuclease) is inactivated while CAD (caspase-activated 
deoxyribonuclease) is indirectly activated by caspase-3.  Caspases 
recognize specific peptide sequences containing an aspartic acid, and 
cleave these substrate proteins immediately following this aspartic 
residue.  The tri- peptide sequence “VAD” is broadly recognized by all 
group 1 caspases.  Z-VAD-FMK is a powerful, irreversible and cell 
permeable inhibitor for caspases.  Z-DEVD-FMK is synthetic peptide 
inhibitor that irreversibly inhibits caspase-3 and related 
protease/caspase activity and blocks apoptosis. DEVD is the specific 
recognition sequence found in poly (ADP-ribose) polymerase (PARP). Z-
LEHD-FMK is a powerful, irreversible and cell permeable inhibitor for 
caspase-9.  The tetra-peptide sequence “LEHD” is preferentially 
recognized by caspase-9.  
Caspase inhibitors are important tools in the investigation of 
many biologic processes utilizing whole cells, cell lysates, and in vivo 
systems.  Caspase inhibitors act by binding to the active site of 
caspases [45].  Flowcytometric analysis of Thp-1 cells pretreated with 
Z-DEVD-FMK and Z-LEHD-FMK exhibited a sub-G1 peak Inhibition in 
DMQA induced cell death (Fig. 3.19)  
 
 
